Peer Review reports
From: Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom
Original Submission | ||
---|---|---|
14 Apr 2022 | Submitted | Original manuscript |
12 May 2022 | Reviewed | Reviewer Report |
24 May 2022 | Reviewed | Reviewer Report - Athanasia Papazafiropoulou |
4 Jun 2022 | Reviewed | Reviewer Report |
15 Jul 2022 | Author responded | Author comments - Kristian B. Filion |
Resubmission - Version 2 | ||
15 Jul 2022 | Submitted | Manuscript version 2 |
18 Jul 2022 | Author responded | Author comments - Kristian B. Filion |
Resubmission - Version 3 | ||
18 Jul 2022 | Submitted | Manuscript version 3 |
19 Jul 2022 | Author responded | Author comments - Kristian B. Filion |
Resubmission - Version 4 | ||
19 Jul 2022 | Submitted | Manuscript version 4 |
24 Jul 2022 | Reviewed | Reviewer Report - Athanasia Papazafiropoulou |
24 Jul 2022 | Reviewed | Reviewer Report |
6 Aug 2022 | Reviewed | Reviewer Report |
17 Aug 2022 | Author responded | Author comments - Kristian B. Filion |
Resubmission - Version 5 | ||
17 Aug 2022 | Submitted | Manuscript version 5 |
26 Aug 2022 | Reviewed | Reviewer Report |
26 Aug 2022 | Reviewed | Reviewer Report |
31 Aug 2022 | Reviewed | Reviewer Report - Athanasia Papazafiropoulou |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
1 Sep 2022 | Editorially accepted | |
29 Sep 2022 | Article published | 10.1186/s12902-022-01140-1 |
You can find further information about peer review here.